Gillian Ellison

Alderley Park
Macclesfield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients.

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 11, 2017

An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice.

An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice.

Journal: Human mutation

Published: June 15, 2017

Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.

Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.

Journal: Seminars in oncology

Published: May 02, 2017

A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories.

A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories.

Journal: British journal of cancer

Published: January 10, 2017

Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples.

Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples.

Journal: Oncotarget

Published: July 16, 2016

A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing.

A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing.

Journal: BMC clinical pathology

Published: October 28, 2014

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.

Journal: Journal of clinical pathology

Published: July 27, 2013

Analytical validation of BRAF mutation testing from circulating free DNA using the amplification refractory mutation testing system.

Analytical validation of BRAF mutation testing from circulating free DNA using the amplification refractory mutation testing system.

Journal: The Journal of molecular diagnostics : JMD

Published: March 11, 2013

EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.

EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.

Journal: Journal of clinical pathology

Published: November 23, 2012

A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples.

A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 03, 2010

Showing 1-10 of 10

Last Updated: 09/26/2026